Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries

Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased risk of stroke and thromboembolism. Anticoagulation with Vitamin K antagonists (VKAs) or with novel oral anti-coagulants (NOACs) represents the cornerstone of the pharmacological treatment to redu...

Full description

Bibliographic Details
Main Authors: P.P. Olimpieri, A. Di Lenarda, F. Mammarella, L. Gozzo, A. Cirilli, M. Cuomo, M.M. Gulizia, F. Colivicchi, G. Murri, D. Gabrielli, F. Trotta
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:International Journal of Cardiology: Heart & Vasculature
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906719302118